15-Deoxy-12,14-prostaglandin J2 inhibits interferon gamma induced MHC class II but not class I expression on ARPE cells through a PPAR gamma independent mechanism

Prostaglandins and Other Lipid Mediators

Volumn 80, Issue 3-4, 2006, Pages 136-143

  Willermain, François ^a,b   Dulku, Simon ^a   Gonzalez, Nathalie Suarez ^b   Blero, Daniel ^b   Driessens, Gregory ^b   De Graef, Chantal ^b   Caspers, Laure ^a   Bruyns, Catherine ^b  

^a SAINT PIERRE UNIVERSITY HOSPITAL   (Belgium)

^b UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

15 Deoxy 12,14 prostaglandin J2; Inflammation; Interferon gamma; MHC class II; PPAR ; Retinal pigment epithelial cells

Indexed keywords

15 DEOXY 12,14 PROSTAGLANDIN J2; GAMMA INTERFERON; INTERCELLULAR ADHESION MOLECULE 1; INTERFERON REGULATORY FACTOR 1; INTERFERON REGULATORY FACTOR 2; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA ANTAGONIST; PROSTAGLANDIN J2; PROTEIN KINASE B; ROSIGLITAZONE; STAT1 PROTEIN; TRANSACTIVATOR PROTEIN; TROGLITAZONE; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; MODULATION; PIGMENT EPITHELIUM; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; TRANSCRIPTION INITIATION;

BIOLOGICAL RESPONSE MODIFIERS; CELL LINE; CELLS, CULTURED; CHROMANS; COCULTURE TECHNIQUES; DINOPROST; ENZYME INHIBITORS; EPITHELIAL CELLS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA-D ANTIGENS; HUMANS; IMMUNOLOGIC FACTORS; INTERCELLULAR ADHESION MOLECULE-1; INTERFERON REGULATORY FACTOR-1; INTERFERON REGULATORY FACTOR-2; INTERFERON TYPE II; INTERFERON-GAMMA; NUCLEAR PROTEINS; PHOSPHORYLATION; PIGMENT EPITHELIUM OF EYE; PPAR GAMMA; PROSTAGLANDIN D2; STAT TRANSCRIPTION FACTORS; T-LYMPHOCYTES; THIAZOLIDINEDIONES; TRANS-ACTIVATORS;

EID: 33748612720     PISSN: 10988823     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prostaglandins.2006.06.001     Document Type: Article

References (24)

1. Willermain F., Caspers-Velu L., Baudson N., et al. Role and expression of CD40 on human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 41 (2000) 3485-3491
2. Willermain F., Caspers-Velu L., Nowak B., et al. Retinal pigment epithelial cells phagocyte T lymphocytes: possible implication in the immune privilege of the eye. Br J Ophthalmol 86 (2002) 1417-1421
3. Chan C.C., Detrick B., Nussenblatt R.B., Palestine A.G., Fujikawa L.S., and Hooks J.J. HLA-DR antigens on retinal pigment epithelial cells from patients with uveitis. Arch Ophthalmol 104 (1986) 725-729
4. Baudoin C., Brinole F., Bayle J., Fredj-Reygrobellet D., Lapalalus P., and Gastaud P. Class II histocompatibility antigen expression by cellular components of vitreous and subretinal fluid in proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci 32 (1991) 2065-2072
5. Hooks J., Chan C., and Detrick B. Identification of the lymphokines, interferon-gamma and interleukin-2 in inflammatory eye diseases. Invest Ophthalmol Vis Sci 29 (1988) 1444
6. Sun D., Enzmann V., Lei S., Sun S.L., Kaplan H.J., and Shao H. Retinal pigment epithelial cells activate uveitogenic T cells when they express high levels of MHC class II molecules, but inhibit T cell activation when they express restricted levels. J Neuroimmunol 144 (2003) 1-8
7. Egwuagu C., Sztein J., Mahdi R., et al. IFN-gamma increase the severity and accelerates the onset of experimental autoimmune uveiitis in transgenic rats. J Immunol 162 (1999) 510-517
8. Clark R. The role of PPARs in inflammation and immunity. J Leukoc Biol 71 (2002) 388-400
9. Harris G., Padilla L., Koumas L., Ray D., and Phipps R. Prostaglandins as modulators of immunity. Trends Immunol 23 (2002) 144-150
10. Kwak B., Myit S., Mulhaupt F., et al. PPARγ but not PPARα ligands are potent repressors of major histocompatibility complex class II induction in atheroma associated cells. Circ Res 90 (2002) 356-362
11. Park E., Park S., Joe E., and Jou I. 15d-PGJ2 and rosiglitazone suppress Janus kinase-STAT inflammatory signaling through induction of suppressor of cytokine signaling 1 (SOCS1) and SOCS3 in glia. J Biol Chem 278 (2003) 14747-14752
12. Kadota Y., Okumura S., Miyoshi S., et al. Altered T cell development in human thymoma is related to impairment of MHC class II transactivator expression induced by interferon-gamma. Clin Exp Immunol 121 (2000) 59-68
13. Schuringa J.J., Wierenga A.T., Kruijer W., and Vellenga E. Constitutive Stat3, Tyr705, and Ser727 phosphorylation in acute myeloid leukemia cells caused by the autocrine secretion of interleukin-6. Blood 95 (2000) 3765-3770
14. Li W., Nagineni C., Hooks J., Chepelinsky A., and Egwuagu C. Interferon-γ signaling in human retinal pigment epithelial cells mediated by STAT1, ICSBP, and IRF1 transcription factor. Invest Ophthalmol Vis Sci 40 (1999) 976-982
15. Rane S., and Reddy E. Janus kinases: components of multiple signalling pathways. Oncogene 19 (2000) 5662-5679
16. Ting J., and Trowsdale J. Genetic control of MHC class II expression. Cell 109 (2002) S21-S33
17. Powell W. 15-Deoxy-PGJ2: endogenous PPARγ ligand or minor eicosanoid degradation product. J Clin Invest 112 (2003) 828-830
18. Vaidya S., Somers P., Wright S., Detmers P., and Bansal V. 15-Deoxy-prostaglandin J2 inhibit the integrin-dependent oxidative burst: involvement of a mechanism distinct from peroxysome proliferator-activated receptor ligation. J Immunol 163 (1999) 6187-6192
19. Monneret G., Hongping L., Vasilescu J., Rokach J., and Powell W. 15-Deoxy-prostaglandin D2 and J2 are potent activators of human eosinophils. J Immunol 168 (2002) 3563-3569
20. Weber S., Scarim A., and Corbett J. Inhibition of IFNγ-induced STAT1 activation by 15-deoxy-prostaglandin J2. Am J Physiol Endocrinol Metab 284 (2003) E883-E891
21. Takeda K., Ichiki T., Tokunou T., Iino N., and Takeshita A. 15 Deoxy prostaglandin J2 and thiazolidinediones activate the MEK/ERK pathway through phosphatidylinositol 3-kinase in vascular smooth muscle cells. J Biol Chem 276 (2001) 48950-48955
22. Xi H., and Blanck G. The IRF-2 DNA binding domain facilitates the activation of the class II transactivator (CIITA) type IV promoter by IRF-1. Mol Immunol 39 (2003) 677-684
23. Li G., Harton J., Zhu X., and Ting J. Downregulation of CIITA function by protein kinase A mediated phosphorylation: mechanism of prostaglandin E, cAMP, and PKA inhibition of class II major histocompatibility complex expression in monocytic lines. Mol Cell Biol 21 (2001) 4626-4635
24. Adamski J., Ma Z., Nozell S., and Benveniste E. 17{beta}-Estradiol inhibits class II MHC expression: influence on histone modifications and CBP recruitment to the class II MHC promoter. Mol Endocrinol 18 (2004) 1963-1974